Hallman Director, Associate Dean
Univ of Waterloo School of Pharmacy, Canada
Dr. Andrea Edginton, PhD, is the Associate Director, Graduate Studies & Research and Associate Professor at the School of Pharmacy at the Univ of Waterloo in Ontario, Canada and Co-Owner of the physiologically-based pharmacokinetic (PBPK) consulting company, Design2Code Inc. Before coming to the Univ, she worked in the Systems Biology group at Bayer Technology Services in Leverkusen, Germany. Dr. Edginton’s academic research focuses on the development and application of PBPK models and simulation techniques in both the areas of pharmaceuticals and human health risk assessment. Her research examines how the physiology of sub-populations such as children and patients with disease affect the pharmacokinetics of drugs and how this information can be integrated into PBPK models for the optimization of drug therapy. Dr. Edginton also heads the modeling component of the Web-Accessible Population Pharmacokinetics Service – Hemophilia (WAPPS-Hemo.org) project that uses population pharmacokinetic modeling factor concentrates and Bayesian forecasting for tailoring treatment prophylaxis in persons with hemophilia.